University of Tennessee Health Science Center: Kenneth Ataga, MD, Co-Authors Paper on Potential New Treatment for Sickle Cell Disease
June 28, 2019
June 28, 2019
MEMPHIS, Tennessee, June 28 -- The University of Tennessee Health Science Center issued the following news:
By Sarah Ashley Bloch
Newly published results from a multinational study co-authored by Kenneth Ataga, MD, director of the Center for Sickle Cell Disease at the University of Tennessee Health Science Center (UTHSC) and the Memphis Consortium for Sickle Cell Disease and Non-Malignant Hematology Research, indicated voxelotor, a novel experimental drug for sickle cel . . .
By Sarah Ashley Bloch
Newly published results from a multinational study co-authored by Kenneth Ataga, MD, director of the Center for Sickle Cell Disease at the University of Tennessee Health Science Center (UTHSC) and the Memphis Consortium for Sickle Cell Disease and Non-Malignant Hematology Research, indicated voxelotor, a novel experimental drug for sickle cel . . .